Sallustio Fabio, Curci Claudia, Stasi Alessandra, De Palma Giuseppe, Divella Chiara, Gramignoli Roberto, Castellano Giuseppe, Gallone Anna, Gesualdo Loreto
Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari "Aldo Moro", Bari 70124, Italy.
Nephrology Unit, Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro", Bari 70124, Italy.
Stem Cells Int. 2019 Apr 4;2019:6795845. doi: 10.1155/2019/6795845. eCollection 2019.
Toll-like receptors (TLRs) represent one of the bridges that regulate the cross-talk between the innate and adaptive immune systems. TLRs interact with molecules shared and preserved by the pathogens of origin but also with endogenous molecules (damage/danger-associated molecular patterns (DAMPs)) that derive from injured tissues. This is probably why TLRs have been found to be expressed on several kinds of stem/progenitor cells (SCs). In these cells, the role of TLRs in the regulation of the basal motility, proliferation, differentiation processes, self-renewal, and immunomodulation has been demonstrated. In this review, we analyze the many different functions that the TLRs assume in SCs, pointing out that they can have different effects, depending on the background and on the kind of ligands that they recognize. Moreover, we discuss the TLR involvement in the response of SC to specific tissue damage and in the reparative processes, as well as how the identification of molecules mediating the differential function of TLR signaling could be decisive for the development of new therapeutic strategies. Considering the available studies on TLRs in SCs, here we address the importance of TLRs in sensing an injury by stem/progenitor cells and in determining their behavior and reparative activity, which is dependent on the conditions. Therefore, it could be conceivable that SCs employed in therapy could be potentially exposed to TLR ligands, which might modulate their therapeutic potential . In this context, to modulate SC proliferation, survival, migration, and differentiation in the pathological environment, we need to better understand the mechanisms of action of TLRs on SCs and learn how to control these receptors and their downstream pathways in a precise way. In this manner, in the future, cell therapy could be improved and made safer.
Toll样受体(TLRs)是调节先天免疫系统和适应性免疫系统之间相互作用的桥梁之一。TLRs不仅与病原体共有的保守分子相互作用,还与源自受损组织的内源性分子(损伤/危险相关分子模式,即DAMPs)相互作用。这可能就是为什么在几种干/祖细胞(SCs)上发现了TLRs的表达。在这些细胞中,TLRs在调节基础运动性、增殖、分化过程、自我更新和免疫调节方面的作用已得到证实。在本综述中,我们分析了TLRs在SCs中发挥的多种不同功能,指出它们可能会因背景和所识别的配体种类而产生不同的影响。此外,我们讨论了TLRs参与SCs对特定组织损伤的反应和修复过程,以及鉴定介导TLR信号差异功能的分子对于开发新治疗策略的决定性作用。考虑到目前关于SCs中TLRs的研究,我们在此阐述TLRs在干细胞/祖细胞感知损伤以及决定其行为和修复活性方面的重要性,而这取决于具体情况。因此,可以想象,用于治疗的SCs可能会潜在地暴露于TLR配体,这可能会调节它们的治疗潜力。在这种情况下,为了在病理环境中调节SCs的增殖、存活、迁移和分化,我们需要更好地理解TLRs对SCs的作用机制,并学会如何精确控制这些受体及其下游通路。通过这种方式,未来细胞治疗可以得到改进并更加安全。